Title : Cost per care of the first year of direct antiviral agents in the Liguria Region: a multicenter analysis.

Pub. Date : 2017

PMID : 28579812






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Detailed analysis of the costs for GT 1 showed the treatment based on ritonavir boosted paritaprevir/ombitasvir + dasabuvir+-RBV with an average cost of $24,978 (RBV+) and $25,448 (RBV-) per patient was the most cost-effective. Ribavirin beta-1,4-galactosyltransferase 1 Homo sapiens
2 Detailed analysis of the costs for GT 1 showed the treatment based on ritonavir boosted paritaprevir/ombitasvir + dasabuvir+-RBV with an average cost of $24,978 (RBV+) and $25,448 (RBV-) per patient was the most cost-effective. Ribavirin beta-1,4-galactosyltransferase 1 Homo sapiens